Insider · CIK 0001478007
Peter S Klein
Files at FFIV (F5, INC.), ACCD (Accolade, Inc.), DNLI (Denali Therapeutics Inc.). First filing -, latest -.
In brief
Peter S Klein files SEC Form 4 as director at FFIV (F5, INC.), and also at ACCD (Accolade, Inc.), DNLI (Denali Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter S Klein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +6,408 | $0.00 | $0 | 33,941 | Jun 5, 2026 |
| Jun 3, 2026 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +19,226 | $0.00 | $0 | 19,226 | Jun 5, 2026 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +6,037 | $0.00 | $0 | 27,533 | Jun 5, 2025 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +18,111 | $0.00 | $0 | 18,111 | Jun 5, 2025 |
| Apr 8, 2025 | ACCD Accolade, Inc. | DDisposition to issuer Common Stock | -28,329 | $7.03 | $199k | 0 | Apr 8, 2025 |
| Apr 8, 2025 | ACCD Accolade, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -35,021 | - | - | 0 | Apr 8, 2025 |
| Apr 8, 2025 | ACCD Accolade, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -20,000 | - | - | 0 | Apr 8, 2025 |
| Apr 8, 2025 | ACCD Accolade, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -8,600 | - | - | 0 | Apr 8, 2025 |
| Mar 12, 2025 | FFIV F5, INC. | MOption exercise Common Stock | +1,309 | $0.00 | $0 | 13,333 | Mar 14, 2025 |
| Mar 12, 2025 | FFIV F5, INC. | MOption exercise Restricted Stock Unitderivative | -1,309 | $0.00 | $0 | 0 | Mar 14, 2025 |
| Mar 13, 2025 | FFIV F5, INC. | AGrant or award Restricted Stock Unitderivative | +934 | $0.00 | $0 | 934 | Mar 14, 2025 |
Questions about Peter S Klein
Answered from the filings on this page, as of the latest one.
Is Peter S Klein buying or selling?
Peter S Klein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter S Klein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter S Klein has 0.
Where does Peter S Klein file Form 4?
Peter S Klein has filed Form 4 at FFIV (F5, INC.); ACCD (Accolade, Inc.); DNLI (Denali Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.